(Q38938738)

7 September 2017

Early iron overload in beta-thalassaemia major: when to start chelation therapy? (English)

1 reference

7 September 2017

0 references

1 reference

Fargion S

1

1 reference

7 September 2017

Taddei MT

2

1 reference

7 September 2017

Gabutti V

3

1 reference

7 September 2017

Piga A

4

1 reference

7 September 2017

Di Palma A

5

1 reference

7 September 2017

Capra L

6

1 reference

7 September 2017

Fontanelli G

7

1 reference

7 September 2017

Avanzini A

8

1 reference

7 September 2017

language of work or name

English

0 references

publication date

1 December 1982

1 reference

Archives of Disease in Childhood

7 September 2017

1 reference

7 September 2017

57

1 reference

7 September 2017

12

1 reference

7 September 2017

929-933

1 reference

Survival and desferrioxamine in thalassaemia major.

7 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1628074

Prevention of iron loading in transfusion-dependent thalassaemia

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1628074

Improvement in iron status and liver function in patients with transfusional iron overload with long-term subcutaneous desferrioxamine

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1628074

Non-specific serum iron in thalassaemia: an abnormal serum iron fraction of potential toxicity

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1628074

Studies on abnormal hemoglobins. I. Their demonstration in sickle cell anemia and other hematologic disorders by means of alkali denaturation.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1628074

Long-term Chelation Therapy in Thalassaemia Major: Effect on Liver Iron Concentration, Liver Histology, and Clinical Progress

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1628074

Long-term desferrioxamine therapy in thalassemia

21 August 2018

1 reference

12 December 2020

Microchromatography of hemoglobins. II. A simplified procedure for the determination of hemoglobin A2

1 reference

12 December 2020

Reassessment of the Use of Desferrioxamine B in Iron Overload

1 reference

12 December 2020

A controlled trial of long-term chelation therapy in homozygous beta-thalassemia

1 reference

12 December 2020

Continuous subcutaenous administration of deferoxamine in patients with iron overload

1 reference

12 December 2020

New approaches to the transfusion management of thalassemia

1 reference

12 December 2020

A non-transferrin-bound serum iron in idiopathic hemochromatosis

1 reference

12 December 2020

Identifiers

DOI

10.1136/ADC.57.12.929

1 reference

7 September 2017

1 reference

7 September 2017

PubMed publication ID

7181522

1 reference